122 related articles for article (PubMed ID: 7530843)
1. Mechanism of inhibition of HIV-1 infection in vitro by guanine-rich oligonucleotides modified at the 5' terminal by dimethoxytrityl residue.
Furukawa H; Momota K; Agatsuma T; Yamamoto I; Kimura S; Shimada K
Nucleic Acids Res; 1994 Dec; 22(25):5621-7. PubMed ID: 7530843
[TBL] [Abstract][Full Text] [Related]
2. Identification of a phosphodiester hexanucleotide that inhibits HIV-1 infection in vitro on covalent linkage of its 5'-end with a dimethoxytrityl residue.
Furukawa H; Momota K; Agatsuma T; Yamamoto I; Kimura S; Shimada K
Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):167-75. PubMed ID: 9212907
[TBL] [Abstract][Full Text] [Related]
3. Guanine-rich oligonucleotide modified at the 5' terminal by dimethoxytrityl residue inhibits HIV-1 replication by specific interaction with the envelope glycoprotein.
Agatsuma T; Yamamoto I; Furukawa H; Nishigaki T
Antiviral Res; 1996 Jul; 31(3):137-48. PubMed ID: 8811198
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human immunodeficiency virus type 1 (HIV-1) penetration into target cells by synthetic peptides mimicking the N-terminus of the HIV-1 transmembrane glycoprotein.
Slepushkin VA; Kornilaeva GV; Andreev SM; Sidorova MV; Petrukhina AO; Matsevich GR; Raduk SV; Grigoriev VB; Makarova TV; Lukashov VV
Virology; 1993 May; 194(1):294-301. PubMed ID: 7683157
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
[TBL] [Abstract][Full Text] [Related]
6. Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion.
Wyatt JR; Vickers TA; Roberson JL; Buckheit RW; Klimkait T; DeBaets E; Davis PW; Rayner B; Imbach JL; Ecker DJ
Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1356-60. PubMed ID: 7906414
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of inhibition of HIV-1 infection in vitro by purified extract of Prunella vulgaris.
Yao XJ; Wainberg MA; Parniak MA
Virology; 1992 Mar; 187(1):56-62. PubMed ID: 1371029
[TBL] [Abstract][Full Text] [Related]
8. Selective antiviral activity of synthetic soluble L-tyrosine and L-dopa melanins against human immunodeficiency virus in vitro.
Montefiori DC; Zhou JY
Antiviral Res; 1991 Jan; 15(1):11-25. PubMed ID: 1709802
[TBL] [Abstract][Full Text] [Related]
9. Native oligodeoxynucleotides specifically active against human immunodeficiency virus type 1 in vitro: a G-quartet-driven effect?
Tondelli L; Colonna FP; Garbesi A; Zanella S; Marongiu ME; Corrias S; Loi AG; La Colla P
Antimicrob Agents Chemother; 1996 Sep; 40(9):2034-8. PubMed ID: 8878576
[TBL] [Abstract][Full Text] [Related]
10. Antiviral action of oligodeoxyguanylic acids against human immunodeficiency virus type 1.
Fujihashi T; Sakata T; Kaji A; Kaji H
AIDS Res Hum Retroviruses; 1995 Apr; 11(4):461-71. PubMed ID: 7543270
[TBL] [Abstract][Full Text] [Related]
11. 5'-linked lipid-oligodeoxyridonucleotide derivatives as inhibitors of human immunodeficiency virus replication.
Kim SG; Nakashima H; Shoji Y; Inagawa T; Yamamoto N; Kinzuka Y; Takai K; Takaku H
Bioorg Med Chem; 1996 Apr; 4(4):603-8. PubMed ID: 8735848
[TBL] [Abstract][Full Text] [Related]
12. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Celada F; Düzgüneş N
J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355
[TBL] [Abstract][Full Text] [Related]
13. Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells.
De Maria A; Pantaleo G; Schnittman SM; Greenhouse JJ; Baseler M; Orenstein JM; Fauci AS
J Immunol; 1991 Apr; 146(7):2220-6. PubMed ID: 1706390
[TBL] [Abstract][Full Text] [Related]
14. MS-8209, a new Amphotericin B derivative that inhibits HIV-1 replication in vitro and restores T-cell activation via the CD3/TcR in HIV-infected CD4+ cells.
Céfai D; Hadida F; Jung M; Debre P; Vernin JG; Seman M
AIDS; 1991 Dec; 5(12):1453-61. PubMed ID: 1726040
[TBL] [Abstract][Full Text] [Related]
15. Effect of Evans blue and trypan blue on syncytia formation and infectivity of human immunodeficiency virus type I and type II in vitro.
Pal R; Mumbauer S; Hoke G; Larocca R; Myers C; Sarngadharan MG; Stein CA
AIDS Res Hum Retroviruses; 1991 Jun; 7(6):537-43. PubMed ID: 1718343
[TBL] [Abstract][Full Text] [Related]
16. Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles.
Sato H; Orenstein J; Dimitrov D; Martin M
Virology; 1992 Feb; 186(2):712-24. PubMed ID: 1370739
[TBL] [Abstract][Full Text] [Related]
17. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
[TBL] [Abstract][Full Text] [Related]
18. The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.
Fischer PB; Collin M; Karlsson GB; James W; Butters TD; Davis SJ; Gordon S; Dwek RA; Platt FM
J Virol; 1995 Sep; 69(9):5791-7. PubMed ID: 7543588
[TBL] [Abstract][Full Text] [Related]
19. Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320).
Buckheit RW; Roberson JL; Lackman-Smith C; Wyatt JR; Vickers TA; Ecker DJ
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1497-506. PubMed ID: 7888204
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibitory activity of polyhydroxycarboxylates derived from phenolic compounds against human immunodeficiency virus replication.
Schols D; Wutzler P; Klöcking R; Helbig B; De Clercq E
J Acquir Immune Defic Syndr (1988); 1991; 4(7):677-85. PubMed ID: 1675677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
